CRSPN.MX
CRISPR Therapeutics AG
MexicoMXNEQUITY
DELAYED
Last price
987.00
■ 0.00 (0.00%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
987.00
Day high
987.00
Day low
987.00
Volume
1
Market cap
—
P/E (TTM)
—
52W range
802.00 – 1,378.00
Trailing performance
Returnvs SPY
1W
+7.87%
+9.1%
1M
+18.20%
+14.9%
3M
+12.67%
+10.3%
6M
+22.04%
+10.2%
YTD
+3.57%
-8.4%
1Y
-8.53%
-28.7%
3Y
+4.67%
-70.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Free account
3 more panels on CRSPN.MX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $0 | $35.00M | $370.00M | $436.00K | -100.0% |
| Operating revenue | $0 | $35.00M | $370.00M | $436.00K | -100.0% |
| Cost of revenue | $213.48M | $120.67M | $130.25M | $110.25M | +76.9% |
| Gross profit | -$213.48M | -$85.67M | $239.75M | -$109.81M | -149.2% |
| Research & development | $381.06M | $310.24M | $387.33M | $461.64M | +22.8% |
| Selling, general & admin | $73.54M | $72.98M | $76.16M | $102.46M | +0.8% |
| Total operating expense | $451.09M | $380.90M | $462.29M | $563.35M | +18.4% |
| Operating income | -$664.57M | -$466.57M | -$222.54M | -$673.16M | -42.4% |
| Pre-tax income | -$577.97M | -$362.67M | -$150.72M | -$650.50M | -59.4% |
| Tax provision | $3.63M | $3.59M | $2.89M | -$325.00K | +1.3% |
| Net income | -$581.60M | -$366.25M | -$153.61M | -$650.17M | -58.8% |
| Net income to common | -$581.60M | -$366.25M | -$153.61M | -$650.17M | -58.8% |
| Basic EPS | -6.47 | -4.34 | -1.94 | -8.36 | -49.1% |
| Diluted EPS | -6.47 | -4.34 | -1.94 | -8.36 | -49.1% |
| EBIT | -$664.57M | -$466.57M | -$222.54M | -$673.16M | -42.4% |
| EBITDA | -$645.09M | -$447.31M | -$202.70M | -$648.99M | -44.2% |
| Basic shares | 89.93M | 84.36M | 79.22M | 77.75M | +6.6% |
| Diluted shares | 89.93M | 84.36M | 79.22M | 77.75M | +6.6% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $347.56M | $298.26M | $389.48M | $211.88M | — | +16.5% |
| Cash & short-term investments | $1.98B | $1.90B | $1.69B | $1.82B | — | +3.8% |
| Accounts receivable | $0 | $25.00M | $200.00M | $0 | — | -100.0% |
| Total current assets | $1.99B | $1.94B | $1.91B | $1.85B | — | +2.5% |
| Property, plant & equipment | $247.57M | $277.55M | $305.94M | $320.56M | — | -10.8% |
| Goodwill & intangibles | — | $0 | $16.00K | $71.00K | $125.00K | — |
| Total assets | $2.27B | $2.24B | $2.23B | $2.24B | — | +1.0% |
| Total current liabilities | $149.12M | $87.78M | $108.79M | $121.11M | — | +69.9% |
| Total debt | $206.75M | $223.69M | $238.63M | $244.02M | — | -7.6% |
| Total liabilities | $343.43M | $309.95M | $346.77M | $367.58M | — | +10.8% |
| Retained earnings | -$1.95B | -$1.37B | -$999.70M | -$846.09M | — | -42.6% |
| Shareholder equity | $1.92B | $1.93B | $1.88B | $1.88B | — | -0.5% |
| Working capital | $1.84B | $1.85B | $1.80B | $1.73B | — | -0.7% |
| Net tangible assets | $1.92B | $1.93B | $1.88B | $1.88B | — | -0.5% |
| Shares issued | 96.01M | 85.91M | 80.21M | 78.69M | — | +11.8% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$581.60M | -$366.25M | -$153.61M | -$650.17M | -58.8% |
| Depreciation & amortisation | $19.48M | $19.26M | $19.84M | $24.17M | +1.1% |
| Stock-based compensation | $72.50M | $86.57M | $81.03M | $97.95M | -16.3% |
| Change in working capital | $71.88M | $156.27M | -$193.59M | $19.84M | -54.0% |
| Operating cash flow | -$345.01M | -$142.77M | -$260.38M | -$495.74M | -141.7% |
| Capital expenditure | -$25.91M | -$1.90M | -$11.97M | -$37.19M | -1,263.2% |
| Investing cash flow | -$31.80M | -$280.48M | $374.65M | -$258.65M | +88.7% |
| Financing cash flow | $426.03M | $331.98M | $62.66M | $38.59M | +28.3% |
| Free cash flow | -$370.93M | -$144.68M | -$272.35M | -$532.93M | -156.4% |
| End cash position | $359.08M | $309.78M | $401.07M | $224.06M | +15.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $10.00M | $1.00M | $0 | $0 | $0 | +900.0% |
| Operating revenue | $10.00M | $1.00M | $0 | $0 | $0 | +900.0% |
| Cost of revenue | $40.27M | $45.95M | $53.70M | $57.12M | $45.15M | -12.4% |
| Gross profit | -$30.27M | -$44.95M | -$53.70M | -$57.12M | -$45.15M | +32.7% |
| Research & development | $69.63M | $68.57M | $83.53M | $58.90M | $166.15M | +1.5% |
| Selling, general & admin | $17.55M | $17.18M | $18.40M | $16.93M | $18.92M | +2.2% |
| Total operating expense | $87.00M | $85.30M | $101.06M | $74.94M | $184.17M | +2.0% |
| Operating income | -$117.27M | -$130.25M | -$154.76M | -$132.06M | -$229.32M | +10.0% |
| Pre-tax income | -$90.19M | -$122.09M | -$130.00M | -$105.82M | -$207.26M | +26.1% |
| Tax provision | $960.00K | $839.00K | $614.00K | $619.00K | $1.29M | +14.4% |
| Net income | -$91.15M | -$122.93M | -$130.61M | -$106.44M | -$208.55M | +25.8% |
| Net income to common | -$91.15M | -$122.93M | -$130.61M | -$106.44M | -$208.55M | +25.8% |
| Basic EPS | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | +26.6% |
| Diluted EPS | -0.94 | -1.28 | -1.37 | -1.17 | -2.40 | +26.6% |
| EBIT | -$117.27M | -$130.25M | -$154.76M | -$132.06M | -$229.32M | +10.0% |
| EBITDA | -$112.99M | -$125.93M | -$149.10M | -$127.63M | -$224.68M | +10.3% |
| Basic shares | 96.51M | 96.05M | 95.27M | 91.31M | 87.07M | +0.5% |
| Diluted shares | 96.51M | 96.05M | 95.27M | 91.31M | 87.07M | +0.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $291.34M | $423.31M | $347.56M | $286.50M | $193.62M | — | -31.2% |
| Cash & short-term investments | $2.36B | $2.44B | $1.98B | $1.92B | $1.72B | — | -3.2% |
| Accounts receivable | — | — | $0 | $0 | $0 | $0 | — |
| Total current assets | $2.37B | $2.45B | $1.99B | $1.93B | $1.73B | — | -3.1% |
| Property, plant & equipment | $233.66M | $240.85M | $247.57M | $255.49M | $262.57M | — | -3.0% |
| Goodwill & intangibles | — | — | — | — | — | — | — |
| Total assets | $2.65B | $2.73B | $2.27B | $2.25B | $2.03B | — | -2.8% |
| Total current liabilities | $132.90M | $136.29M | $149.12M | $118.96M | $104.36M | — | -2.5% |
| Long-term debt | $586.20M | $585.47M | — | — | — | — | +0.1% |
| Total debt | $783.75M | $787.64M | $206.75M | $211.02M | $215.45M | — | -0.5% |
| Total liabilities | $904.22M | $911.26M | $343.43M | $329.33M | $318.59M | — | -0.8% |
| Retained earnings | -$2.16B | -$2.07B | -$1.95B | -$1.82B | -$1.71B | — | -4.4% |
| Shareholder equity | $1.75B | $1.81B | $1.92B | $1.92B | $1.71B | — | -3.7% |
| Working capital | $2.24B | $2.31B | $1.84B | $1.81B | $1.63B | — | -3.2% |
| Net tangible assets | $1.75B | $1.81B | $1.92B | $1.92B | $1.71B | — | -3.7% |
| Shares issued | 96.66M | 96.50M | 96.01M | 94.00M | 88.55M | — | +0.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$91.15M | -$122.93M | -$130.61M | -$106.44M | -$208.55M | +25.8% |
| Depreciation & amortisation | $4.28M | $4.32M | $5.66M | $4.43M | $4.65M | -0.9% |
| Stock-based compensation | $17.32M | $16.32M | $18.08M | $16.60M | $17.61M | +6.1% |
| Change in working capital | -$3.70M | -$15.41M | $22.64M | $10.91M | -$16.51M | +76.0% |
| Operating cash flow | -$83.50M | -$108.90M | -$92.55M | -$84.63M | -$113.88M | +23.3% |
| Capital expenditure | -$3.12M | -$504.00K | -$517.00K | -$74.00K | -$25.12M | -519.2% |
| Investing cash flow | -$55.66M | -$410.74M | $37.20M | -$119.23M | $69.98M | +86.4% |
| Financing cash flow | $7.18M | $591.91M | $116.41M | $296.77M | $2.26M | -98.8% |
| Free cash flow | -$86.62M | -$109.40M | -$93.07M | -$84.71M | -$139.00M | +20.8% |
| End cash position | $299.34M | $431.31M | $359.08M | $298.02M | $205.14M | -30.6% |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
919.20
+7.38% from price
SMA 20
881.67
+11.95% from price
SMA 50
904.16
+9.16% from price
SMA 100
908.72
+8.61% from price
SMA 200
933.83
+5.69% from price
EMA 12
915.22
+7.84% from price
EMA 26
900.29
+9.63% from price
EMA 50
900.07
+9.66% from price
RSI (14)
75.0
Overbought
MACD (12,26,9)
14.93
Hist 10.57
ATR (14)
14.71
1.49% of price
Realised vol 30D
71.7%
Annualised
Bollinger upper
986.12
20, 2σ
Bollinger lower
777.23
20, 2σ
50 / 200 cross
Death
904.16 vs 933.83
Trend bias
Above 200
+5.69%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.26
Less volatile than market
Correlation to SPY
0.05
Largely independent
Realised vol 30D
71.7%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-41.3%
Peak to trough
Max drawdown 5Y
-71.6%
Peak to trough
ATR 14
14.71
1.49% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Despair and anger erupt after deadly Guinea landfill collapse
AFP · 5m ago
BC-Nikkei 225 Futures
Associated Press · 9m ago
Nearly 80% of Grocery Shoppers Use Digital Tools Before or During a Trip, Intouch Insight Study Finds
GlobeNewswire · 9m ago
The Lancet Neurology Publishes Data From Alkermes’ Positive Vibrance-1 Phase 2 Study of Alixorexton in Adults With Narcolepsy Type 1
Business Wire · 9m ago
Coming Soon: First Horizon Bank to Open New Banking Center in Houston Area
PR Newswire · 9m ago
Fabrinet (FN) Q4 2026 Earnings Call Transcript
Motley Fool · 10m ago
Canada will announce retaliatory tariffs against the United States on Tuesday, AP source says
Associated Press · 11m ago
California American Water Supports Cal Fire Response to Timber Fire
PR Newswire · 12m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.